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ABSTRACT
A Quality Improvement Initiative for Intraoperative Low Dose Ketamine Utilization in
Thoracotomy
Jason Wampler, BSN, SRNA
The challenge of postoperative pain control following a thoracotomy is well noted among
anesthesia providers. The intraoperative utilization of low-dose ketamine in several patient
populations, including those undergoing a thoracotomy, has been deemed a viable intervention in
the multi-modal analgesia plan at not only reducing postoperative pain scores for patients, but
also reducing opioid consumption. This quality improvement project sought to increase provider
awareness of this intervention among anesthesia providers in a community hospital with a goal to
influence a practice change. This was completed using a pre-post design centered around an
educational in-service, with an additional 60-day follow-up survey to gather provider feedback
on the success of the in-service. Baseline knowledge and utilization of this technique was
determined prior to the educational offering. Statistically significant improvement in the
knowledge of low-dose ketamine was noted and all providers indicated a willingness to
implement this practice change. Despite low volumes of this patient population in this
community hospital, those providers who did implement the use of low-dose ketamine felt both
postoperative pain and opioid consumption were reduced.
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A Quality Improvement Initiative for Intraoperative Low Dose Ketamine Utilization in
Thoracotomy
Postoperative pain control following a thoracotomy is a major challenge acknowledged
by anesthesia providers. Opioid utilization has long been identified as the standard of care for
postoperative pain relief. However, today’s anesthetists are frequently challenged to adopt a
multi-modal pain relief strategy that minimizes opioid consumption for patients. The
intraoperative utilization of low-dose ketamine in several patient populations, including those
undergoing a thoracotomy, has been deemed a viable intervention in the multi-modal analgesia
plan at not only reducing postoperative pain scores for patients, but also reducing opioid
consumption. This quality improvement project sought to increase provider awareness of this
intervention among anesthesia providers in a community hospital with a goal to influence a
practice change.
Background
A thoracotomy is an invasive, major surgical procedure fraught with challenges to patient
recovery. Gerner (2008) describes the postoperative pain following thoracotomy as “very severe,
probably the most severe pain experienced after surgery”. Soto and Fu (2003) identified pain
management as the “key component in the alteration of lung function after thoracic surgery”.
The use of opioids in the postoperative recovery, specifically via intravenous (IV) or epidural
patient-controlled analgesia (PCA), has long been the gold standard of care after thoracotomy.
However, the list of potential adverse effects of opioids is extensive, not the least of which is
respiratory depression and sedation, which directly counter the ability to cough, deep breath, and
ambulate. Health care providers must target interventions that decrease pain and limit opioid
consumption. This quality improvement project promotes the benefits of utilizing intra-operative
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low-dose ketamine in reducing postoperative pain and opioid consumption following
thoracotomy procedures.
Problem Description
A thoracotomy is an invasive surgery, allowing a surgeon to access the thoracic cavity of
the chest. Lazopoulos et al. (2015) note that the most common type of thoracotomy is the
posterolateral approach, an approximately six-inch-long incision through all layers of tissue and
rib displacement typically between the fifth and sixth ribs (American Lung Association, 2020),
as this allows the best visualization of the thoracic cavity. A patient may require a thoracotomy
for a variety of conditions or disease processes, the most common of which is lung cancer.
Surgery is a viable treatment in lung cancer, specifically non-small cell lung cancer (American
Cancer Society, 2019). If the cancer is identified in early stages while still confined to the lung, a
thoracotomy can be performed to remove the cancerous portion of the lung and can be a curative
intervention. However, this approach creates many challenges to patient recovery, including
significant postoperative pain.
Acute pain is perhaps the most well-known and common barrier to patient recovery
following a thoracotomy procedure. Acute pain creates both physical and mental stress for the
patient, as well as hindering critical interventions required to prevent postoperative
complications. In this patient population, the ability to cough, deep breath, and ambulate are
critical components to recovery. Coughing and deep breathing increases lung expansion,
mobilizes secretions, and prevents the development of atelectasis and pneumonia. Ambulation
also increases lung expansion, as well as deceasing the risk of deep vein thrombosis and
deconditioning. Splinting from severe pain can hinder these essential interventions and directly
contribute to postoperative respiratory complications. Pehlivan et al. (2019) assert the
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management of pain in this population is difficult and complex, as the source of the pain is multifactorial, emanating from both the chest wall and lungs themselves, with the presence of chest
tubes in the postoperative recovery period contributing to the persistent existence of pain.
Opioids are a standard inclusion in the multi-modal pain management of thoracotomies;
however, the potential adverse effects of opioids can create new complications and barriers to
patient recovery. The list of potential adverse effects of opioids is extensive, not the least of
which is respiratory depression and sedation, which directly counter the ability to cough, deep
breath, and ambulate. As opioid consumption increases, so does the risk of adverse effects. The
use of continuous infusion of opioids, via IV or epidural PCA administration, has traditionally
been the gold standard in the acute recovery period (Batchelor et al, 2019). This continuous
infusion helps to maintain a more consistent pain level, but also may lead to opioid tolerance,
thus requiring increasing doses. Additionally, 1 in 7 opioid naïve patients are at risk for opioid
dependency following lung surgery (Harrington, 2018). In order to enhance recovery from
thoracotomy procedures, health care providers must target interventions to decrease pain, and
ideally, limit opioid consumption.
Ketamine is a N-methyl-D-aspartate receptor antagonist with both analgesic and
anesthetic properties. It produces a “profound analgesia and amnesia yet retains most protective
reflexes” (Nagelhout & Elisha, 2018). Subramaniam et al. (2019) note that “ketamine has been
used successfully as an adjunct analgesic to decrease postoperative opioid requirements in many
clinical trials.” In addition to standard analgesia, it can be protective from opioid-induced
hyperalgesia, a phenomenon of increased pain after large doses of opioids have been used and
abruptly discontinued, as is common after general anesthesia for major surgeries.
Pharmacodynamically, ketamine has several very useful properties. In the cardiovascular system,
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ketamine acts as a stimulant, increasing heart rate, blood pressure, and cardiac output. In the
respiratory system, ketamine decreases pulmonary resistance, allows for normal respiration to be
maintained, and “is the only bronchodilating induction agent and the agent of choice in any
patient with active asthma who requires surgery” (Nagelhout & Elisha, 2018). Studies have
shown that the intraoperative use of IV ketamine in major surgeries, including thoracotomies,
can reduce acute postoperative pain, reduce opioid consumption, and improve patient outcomes.
Malignant neoplasms have the second highest mortality rate in both the state of Maryland
and Allegany County (Maryland Department of Health, 2020). Despite an annual decline in
incidence levels since 2003, lung cancer remains the deadliest malignant neoplasm in the state of
Maryland. As of 2017, Maryland has a lung cancer incidence of 54.6 per 100,000, and a
mortality rate of 36.1 per 100,000, figures that are slightly better than the national average (U.S.
Cancer Statistics, 2017). However, lung cancer remains a far greater torment in Allegany
County, Maryland. As of 2017, Allegany County has a lung cancer incidence rate of 78.5 per
100,000, and a mortality rate of 47.3 per 100,000, appreciably exceeding the state in both
measures. In fact, lung cancer accounted for approximately 28% of all cancer deaths in Allegany
County from 2013-2017, significantly exceeding all other cancer types.
Problem Statement
The recovery from a thoracotomy is a considerable challenge, for both patient and
provider, witnessed first-hand by the co-lead investigator over the last seven years in the
Cardiovascular Intensive Care Unit (CVICU) in a large community hospital located in Allegany
County, Maryland. Providers have thus far been unable to implement successful interventions to
best decrease pain and limit opioid consumption in this patient population.
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Available Knowledge
A problem, intervention, control, outcome, time (PICOT) question was developed to
guide the literature search for this project. The PICOT utilized was: In thoracotomy patients, how
does intraoperative IV administration of low-dose ketamine compared to no administration of
ketamine impact IV opioid consumption within the first hour in the post-anesthesia care unit
(PACU)? A search for studies regarding the intraoperative use of ketamine in thoracotomy
procedures was performed using an advanced search in the EBSCOhost Research Databases
interface accessed through the West Virginia University Health Sciences Library. Specific
databases utilized in this interface were: Academic Search Complete, CINAHL with Full Text,
Health Source: Nursing /Academic Edition, and MEDLINE. Using the individual elements of the
PICOT ultimately yielded 24 possible articles for review. The element of the PICOT proving
most difficult to evaluate was the population. Studies are limited in availability in the utilization
of intraoperative ketamine in thoracotomies; therefore, similarly invasive surgical procedures
were included. After reviewing all articles produced in the systematic search, it was determined
that five articles providing appropriate evidence were sufficient to answer the PICOT. An
evaluation table, located in Appendix A, was prepared to delineate the various details of each
study chosen for review.
Literature Review
Kaur, Saroa, & Aggarwal. Kaur et al. (2015) hypothesized that utilizing intraoperative
low-dose ketamine may have an opioid sparing effect in an open cholecystectomy. Despite
including a different patient population, this study brings a wealth of insight into the efficacy of
intraoperative ketamine. The statistical difference in pain scores between the control and
intervention groups lasted for only the first six hours postoperatively, shorter than other studies.
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However, a decrease in reported pain during this six-hour window may account for the
significant reduction in total opioid consumption. A key statistic in this study involved the
requirement of a rescue analgesic. IV Morphine was administered as a weight-based rescue
analgesic in the post anesthesia care unit (PACU) if the patient reported a visual analog score
(VAS) score > 3. Only 5/40 ketamine patients required a rescue analgesic dose of IV morphine,
compared to 40/40 in the control group. Based on this result alone, the use of ketamine could be
recommended to decrease postoperative pain and ultimately, limit the need for a rescue
analgesic. To control for confounding factors, the authors note that intraoperative opioids were
not used, so as to not mask the effectiveness of ketamine.
Choi et al. Choi et al. (2015) established opioid-induced hyperalgesia (OIH) can be
induced by high-dose remifentanil, and that OIH and opioid consumption can be diminished with
intraoperative ketamine use. OIH is a phenomenon of increased pain after high-dose opioid use
and abrupt discontinuation, as can be seen under general anesthesia during procedures. This
study, conducted during laparoscopic gynecology surgery, included three groups: group RL
received low-dose remifentanil, group RH high-dose remifentanil, and group KRH a
combination of high-dose remifentanil and ketamine, as well as a ketamine bolus at induction. In
the PACU, ketorolac 30 milligrams (mg) IV was administered when the patient reported numeric
pain score (NRS) exceeding 4 on a 0-10 scale. Additional 15 mg doses were administered for
each successive NRS score > 4 in the PACU. While not reaching statistical significance, group
RH received the first analgesic earliest. Group RH required significantly more total analgesic
compared to group RL in the PACU. Compared to both groups, group RH reported significantly
higher pain scores at 6 and 24 hours and required higher cumulative fentanyl dosing in the first
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48 hours. These statistics demonstrate that OIH can be induced by high doses of remifentanil and
this phenomenon may be offset with the addition of ketamine.
Ozyalcin et al. Ozyalcin et al. (2004) evaluated the efficacy of preemptive ketamine via
intramuscular (IM) and epidural routes in thoracotomy to control acute and chronic postoperative
pain in a placebo-controlled trial. The greatest limitation of this study is likely its publication
date, as it was in 2004. Despite this date, this study was not without merit. The patient
population, intervention, comparison group, and outcomes measured are all an ideal match for
this project. Of note, ketamine was administered as an intraoperative bolus only and yet still
received positive results in significantly decreasing pain and opioid consumption. This suggests
that a continuous infusion of ketamine is not necessary to still be effective.
Subramaniam et al. Subramaniam et al. (2011) sought to “demonstrate the analgesic
efficacy and opioid-sparing effect of low dose ketamine in patients undergoing lumbar
laminectomy and fusion procedures”. The study extended a ketamine infusion for 24 hours after
surgery. The most notable difference, as illustrated in the synthesis table in Appendix B, is this is
the only study to include the chronic preoperative use of opioids as an inclusion criterion,
whereas each other study explicitly lists this as an exclusion criterion. Subramaniam and his
partners theorized that ketamine would have an opioid-sparing effect for those who have a
history of chronic opioid use, as is common for those with chronic back pain. The authors note in
their discussion that chronic use was defined as a minimum of two weeks of use prior to surgery;
however, the drug, dose, and total duration of use were not controlled or analyzed, and this could
have potentially influenced the results of the trial.
A sample size of 26 patients per group was needed to reach 90% statistical power.
Ultimately a sample size of only 15 for each group was obtained; therefore, this study did not
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reach the predetermined number for an appropriate evaluation of significance. After
collaboration between providers and the research team, clinical judgement was used to halt the
study. Two specific reasons were given for halting the study. First, it was felt that neither group
had an obvious reduction in pain or opioid use. The second reason given for stopping the trial
was a concern over the number of patients exhibiting CNS side effects; however, most of the
patients exhibiting CNS side effects were in the saline control group, including four of the six
suffering hallucinations or confusion.
Pehlivan et al. Pehlivan et al. (2019) hypothesized that low-dose ketamine will reduce
acute and chronic pain after thoracotomy surgeries. This study, the most recently published, had
many encouraging outcomes. This study was performed with thoracotomy patients and, like
Subramaniam, continued the ketamine infusion for 24 hours after surgery completion. Unlike
Subramaniam, this study saw a significant reduction in VAS both at rest and with coughing for
the first 24 hours postoperatively. Total morphine consumption was also significantly reduced.
Literature Synthesis
A synthesis table, found in Appendix B, illustrates the notable similarities and differences
among the studies. Each study utilizes intraoperative IV ketamine (intervention) and evaluates its
effect on postoperative pain and opioid consumption (outcome). In addition, each study is a
randomized control trial, testing ketamine against a control group. As previously stated, the
limited availability of studies including in the utilization of intraoperative ketamine in
thoracotomies required the search be expanded to similarly invasive surgical procedures. These
studies across a variety of surgical populations have shown that intraoperative use of low-dose
ketamine can enhance patient recovery by decreasing both postoperative pain and cumulative
opioid consumption.
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Recommendations for Practice
Based on this review, low-dose ketamine would be an appropriate intraoperative
medication to add to the multi-modal pain management of thoracotomy patients. Careful review
and contemplation of the above studies should be applied to guide this practice. Rosenbaum,
Gupta, and Palacios (2020) define a critical dose for ketamine administration as 1 to 1.5 mg/kg
IV. They state that doses below this threshold achieve both analgesia and sedation; however,
when exceeded, the patient may enter a dissociative state. The range of doses used in these five
studies is 0.1-0.3 mg/kg IV, well below this established threshold. The potential for CNS effects
of ketamine are well-known; however, very few of the studies report such adverse reactions. This
can likely be attributed to the low-dose regimen. Based on the evidence provided in these five
studies, low-dose ketamine can be safely infused within the intraoperative period as a bolus
and/or continuous infusion. Also, of particular importance to the repeated bolus method, Daily
Med (2019) provides recommendations that subsequent dosing of ketamine does not produce
significant cumulative effects. Finally, opioid use in postoperative management of pain in
thoracotomy patients is still valuable and is generally a necessary intervention for patient
comfort and recovery. In each study reviewed, ketamine is an adjunct in pain management, not
the sole treatment. Despite the potential pitfalls of opioid use, severe acute pain after
thoracotomy procedures cannot be managed by ketamine alone. In each study, opioids, primarily
administered using a PCA, were employed for pain management.
Theoretical Framework
The Stetler Model of evidence-based practice (Stetler, 2001) is the theoretical framework
applied to guide this project. This is a five-step, or phase, process that aims to translate evidence
into practice. The first phase is “Preparation”, in which the problem is identified. This phase has
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been completed, as the project leader identified the problem of severe pain following
thoracotomy through personal experience while working in the community hospital CVICU. The
possible solution to this problem was obtained in consultation with the faculty of record, Dr.
Mike Frame, as well as the community hospital’s co-chief Certified Registered Nurse Anesthetist
(CRNA). Phase two of the model is termed “Validation”, and this phase involves evaluating a
wide range of available evidence and determining its appropriateness for the problem. This phase
was completed in conjunction with the literature search of the PICOT. Phase three is
“Comparative Evaluation/Decision Making”. This phase is best described as a literature
synthesis and discussion and has also been completed for this project. Phase four is the
“Translation/Application” step. This step synthesizes the findings of the evidence into an
actionable plan for dissemination and represents the purpose of this project. The final phase is
“Evaluation”. This was completed by using a pre-post design centered around the educational inservice, with an additional 60-day follow-up survey to gather provider feedback on the success
of the in-service.
Specific Aims
The first aim was to increase knowledge of low-dose ketamine and the benefits it may
bestow upon the patient’s recovery through an educational delivery of available evidence. The
goal of increased awareness was to influence a practice change for utilization of low-dose
ketamine resulting in reduced consumption of opioids and postoperative pain. The second aim
was to develop guidelines for the use of intraoperative low-dose ketamine utilization in
thoracotomy procedures, with an overall goal of the delivery of safe and effective anesthesia.
The final aim was to evaluate if increased awareness has influenced a practice change and if
providers feel the change has been beneficial on the postoperative recovery period for patients.
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Purpose Statement
The purpose of this project was to promote awareness within the Anesthesia Department
of a large community hospital, via an educational in-service, regarding the benefits of utilizing
intraoperative low-dose ketamine in reducing postoperative pain and opioid consumption
following thoracotomy procedures.
Methods
Context
This DNP project was implemented at a large community hospital in Cumberland, MD.
The audience for this project is CRNAs and Anesthesiologists of the Anesthesia Department at
this institution. The specific patient population discussed were patients undergoing a
thoracotomy procedure, a surgery performed at this hospital.
Intervention
To achieve the primary objective of the project, an educational in-service was developed
detailing the benefits of intraoperative low-dose ketamine utilization on postoperative pain and
opioid consumption among thoracotomy patients. An outline of this educational offering is
located in Appendix D. This presentation was developed using PowerPoint software to aid in the
content delivery. The actual delivery method of this information was via live presentation. The
in-service began with a brief outline of the background and significance of pain and opioid
consumption after thoracotomy as previously described in this proposal. Next, a summation of
the literature was given to establish the benefits of low-dose ketamine. At this point, the dose
range that represents “low-dose” for ketamine was defined. Guidelines for ketamine utilization
were established and offered for consideration by the anesthesia providers. The DNP project
team determined a recommended dose for ketamine bolus at induction. Two options were
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provided for anesthesia maintenance: continuous infusion and bolus method. The guidelines for
use also include contraindications to use, precautions, and special considerations. A summation
of the recommendations for utilization can be reviewed in Appendix E and was also provided to
the audience in a separate digital document as a reference if implementation was chosen.
Feasibility Analysis
There were very few barriers to the dissemination of this evidence showing that
intraoperative low-dose ketamine can reduce postoperative pain and opioid consumption. There
were no privacy concerns or technical limitations. The content of the presentation was
synthesized by the project team from published evidence and protocols already in use at other
facilities. The only requirement was educating the anesthesia department through an in-person
forum. No cost burden was associated with disseminating the synthesis of evidence, and only a
small amount of time was required by the staff to acquire this new knowledge. The staff was
asked to take the time to participate in a pre-survey to determine any knowledge deficit and an
end-of-session questionnaire to measure success as evidenced by correct awareness of such
things as low-dose ranges. Success was also measured in provider willingness to try low-dose
ketamine during thoracotomy surgery which was measured in a follow-up survey 60-days after
evidence dissemination.
Very few barriers existed to the actual implementation of this practice change. The
proposed practice change does not place any extra demands on currently available resources.
Utilizing low-dose ketamine, especially using a bolus method verses an infusion, does not alter
the current workflow or effort of anesthesia providers during a thoracotomy, and using this
medication is certainly within the skillset of the anesthesia team. In addition, the cost of
ketamine is low, with 50 mg/ml vials costing only $5.17 per 10ml vial. Reduced opioid
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consumption may also be of financial benefit. Minimal adverse effects of low-dose ketamine are
present in current evidence.
Needs Assessment
The goal of this DNP project was to increase anesthesia provider awareness of low-dose
ketamine, encouraging a practice change by increasing knowledge of the benefits in thoracotomy
as well as alleviating possible concerns of adverse reactions. In order to meet this goal, the
primary requirement was a forum in which to disseminate the evidence and proposed practice
change. The primary stakeholder for this audience was the anesthesia care team. In an attempt to
influence this practice change, the DNP project team developed well-rounded guidelines and
recommendations for the utilization of this medication and technique. If the value of the
evidence was accepted, and individual practitioners chose to incorporate low-dose IV ketamine
into their practice, then PACU staff and the cardiothoracic surgery team responsible for
postoperative care were informed about the ketamine utilization. As with any anesthetic, the
anesthesia provider should have made the patient aware of the planned medications they are to
receive while under anesthesia including the intended benefits and possible risks.
SWOT Analysis
As with any project, both pros and cons exist and must be analyzed and considered. The
main strength of this project was the support it received within the community hospital. The cochief CRNA expressed support of this practice change and offered a letter of support for this
project (see Appendix F). A facility anesthesiologist was very encouraging as well and felt that
ketamine was underutilized at the institution. Also, the cardiothoracic surgeon also offered to
support this practice change in the anesthesia care of thoracotomies. Finally, the Vice President
and Chief Nursing Officer also offered his support for this project. The financial cost of
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dissemination was nil, and only a small amount of time was asked of the anesthesia department
to listen and participate in surveys to measure the project’s success and offer feedback on the
presented information based on their clinical experience. The low cost of ketamine and an
anticipated decreased in opioid consumption, while not specifically examined, could potentially
lead to a cost savings in addition to improving patient outcomes. One significant weakness
appreciated was that, as a community hospital, the institution handles a lower volume of
thoracotomies compared to larger facilities.
One significant opportunity for this project was this hospital site in Cumberland,
Maryland was recently acquired by a large academic institution, increasing the resources and
exposures to new evidence-based practices such low-dose ketamine utilization. A threat
identified to this project arises from the nature of the pharmaceutical industry. Newer medicines
are being developed every day, and a new and improved medication may become available that
prove superior to ketamine in the pain management of this population. While a cutting-edge
medication that could improve pain control and management would be welcomed, the usefulness
of ketamine, and the value of this in-service, could be eclipsed a new medication emerge.
Sustainability
This project stemmed from a conversation with one of the co-chief CRNAs, who
expressed a desire to implement elements of the Extended Recovery After Surgery (ERAS)
guidelines in practice as this facility. Ketamine is a medication frequently included in multiple
ERAS surgical population recommendations and protocols. The evidence reviewed for this
project demonstrates the efficacy of low-dose ketamine in other major surgeries, and thus could
be used by anesthesia providers at this facility in other surgical populations. Additionally, longterm impacts from this project could result in the stimulus needed to introduce broader ERAS
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recommendations for not only lung surgery but other surgical populations as well. In the shortterm, team member Jared Lamp, CRNA offered his support of ensuring the continued success of
this project.
Project Team.
This project was led by co-chief investigator Jason Wampler, SRNA. Dr. Mike Frame,
CRNA served as the faculty of record and chief investigator and provided guidance through each
phase of the project. Jared Lamp, CRNA served as a content expert and, as a staff nurse
anesthetist at the community hospital, a facilitator and resource to the anesthesia team after the
evidence was presented.
Congruence with Organization
The mission statement at the hospital is: “We are dedicated to providing patient-centered
care and improving the health and well-being of people in the communities we serve” (UPMC
Western Maryland, 2020). Six core values serve as pillars for all programs at the institution:
integrity, innovation, compassion, accountability, respect, and excellence. The use of low-dose
ketamine to reduce postoperative pain and opioid consumption is a patient-centered approach,
aligning with the institution’s desire to be innovative, seeking improvement through new
practices; compassionate, showing care and kindness to patients; and excellence, striving for
superior performance.
Timeline
The goal was to present this project proposal for IRB review no later than October 31,
2020. December 31, 2020, was the target date for final IRB approval and complete development
of the educational in-service and surveys. The intervention was implemented on Tuesday, March
2, 2021, to the Anesthesia Department. Sixty days was provided to allow for implementation of
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this evidence into their practice. Within this time, initial data from the pre-post design was
analyzed. After these sixty days, the final follow-up survey was administered to gather provider
feedback. The Fall of 2021 was devoted to completing data analysis and composing the final
DNP project poster. Summer 2022 was the target for the final DNP project presentation. Please
refer to the SMART Work Plan is Appendix C for a more detailed description of this timeline.
Evaluation Plan
A pre-post design was utilized to evaluate the purpose of this project. Prior to the
presentation, anesthesia providers were asked to take a short survey evaluating current
knowledge of low-dose ketamine and determining prior utilization of this technique. This
established a baseline of current knowledge and practice. The end-of-session questionnaire
compared newly gained knowledge to the baseline to establish if learning occurred. The
providers were also asked to rate on a Likert scale the likelihood of adopting this evidence into
practice which indicated that the evidence had influenced a practice change. A second survey,
occurring sixty-days following the in-service, determined if any providers had implemented the
evidence of this in-service, as well as gathering any feedback based on their clinical experience
with this practice change. Providers were also granted a forum to explain why they may have
been hesitant to adopt this practice change, giving the DNP team a chance to understand why the
evidence may not have influenced a practice change.
Measures
Project Objectives
The Centers for Disease Control and Prevention (CDC) evaluation brief “Writing
SMART Objectives” (2018) was used to develop clearly stated, feasible, and measurable
objectives for this project. The SMART acronym stands for specific, measurable, achievable,
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realistic, and time phased. The main objective was the purpose of this project, to promote
awareness within the Anesthesia Department, via an educational in-service, regarding the
benefits of utilizing intraoperative low-dose ketamine in reducing postoperative pain and opioid
consumption following thoracotomy procedures. The secondary objective was to influence a
practice change, utilizing low-dose ketamine in anesthesia care during thoracotomy procedures,
using the same in-service. The overall goal was to improve anesthesia care.
Objective Evaluation
To evaluate the first objective, increased awareness, a pre-post design was utilized. Prior
to the presentation, anesthesia providers were asked to take a short survey evaluating current
knowledge of low-dose ketamine and determining prior utilization of this technique. This
established a baseline of current knowledge and practice. Following the presentation, anesthesia
providers were asked to take an end-of-session questionnaire to evaluate comprehension of the
presentation’s content and to survey their willingness to utilize intraoperative low-dose ketamine
among thoracotomy patients in their practice. The questionnaire (1) established if the educational
in-service was successful in promoting anesthesia provider awareness regarding the benefits of
low-dose ketamine, (2) determined whether greater awareness was likely to translate into a
practice change among these providers, and (3) allowed those who were resistant to this practice
change an opportunity to express their concerns. In this pre-post design, the in-service
represented the starting event, and each survey consisted of a combination of closed and openended questions. Likert scale questions were added to the end-of-session questionnaire to
measure willingness to adopt this practice change.
To evaluate the second objective, if a practice change has been influenced, a 60-day
evaluation period was provided to allow providers the opportunity to institute the evidence
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presented into their practice. As this project was an educational in-service to increase awareness
of low-dose ketamine, the participants were informed that this change was not mandated;
however, they were encouraged to trial this technique. After this time, an additional survey was
administered to (1) determine if any anesthesia providers had made a practice change, (2) gather
feedback on the effectiveness of this practice change based on the provider’s clinical judgement,
(3) allow providers to offer recommendations with respect to the presented guidelines based on
their recent clinical experience using ketamine, and (4) allow those who were resistant to this
practice change an opportunity to express their concerns. As with the end-of-session
questionnaire, this survey consisted of closed, open-ended, and Likert scale questions. Data was
compared from the baseline survey (has there been any prior utilization of low-dose ketamine) to
the end-of-session questionnaire (would any providers be willing to utilize this technique) to this
final evaluation (has the evidence been implemented) to determine if the in-service influenced a
favorable practice change. Survey questions may be reviewed in Appendix G.
The anesthesia care plan is individualized for each patient and developed based on patient
preference, history, and the clinical experience of individual providers. No patient data was
collected. The surveys collected subjective data concerning the provider’s recent clinical
experiences utilizing low-dose ketamine.
Approach for Ongoing Assessment
The 60-day follow-up survey functioned as the ongoing assessment of this project. As
previously stated, in addition to determining if providers implemented the evidence presented,
this survey gathered feedback from the providers based on their individual clinical experience.
This feedback will be used to make any necessary updates to the recommended guidelines as
previously presented; what has worked, what has not. It also served to inform the DNP team
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what information was most useful and if any potentially valuable information was omitted. This
feedback can only be obtained through clinical experience and evaluation; therefore, it is vital to
collect.
Analysis
No survey instrument was found that compliments this intervention. Therefore, questions
for the project surveys were developed by the project investigator. Once developed, the surveys
were entered into Qualtrics XM software and distributed to the Anesthesia Department members
electronically in accordance with the established timeline. This system allowed for anonymous
feedback and additional time for provider response. Nine CRNAs responded to each survey,
although only three were afforded the opportunity to perform a thoracotomy during the allotted
timeframe of this project.
All data was analyzed via IBM SPSS software. A one-sample T-test was used to evaluate
effectiveness of teaching, if the CRNA felt ketamine was effective in reducing pain and opioid
consumption, and if a practice change had been influenced. Dr. Laurie Theeke, former West
Virginia University School of Nursing professor and PhD Program Director, assisted in data
analysis.
Ethical Considerations
The intervention of this project was an educational in-service regarding the benefits of
low-dose ketamine in the postoperative recovery of thoracotomy patients. As this was an inservice, there was no mandate that providers implement this intervention, only that they consider
the merits of the evidence presented from the systematic review of this subject. Anesthesia
provider feedback was anonymous using Qualtrics XM software. The use of ketamine in general
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anesthesia is a federally approved indication for this drug. This was not an experimental
intervention or clinical trial; therefore, no patient information was collected.
The proposal was submitted for IRB review at the West Virginia University to obtain
approval for the research. The intervention of this project was reviewed the Director of Medical
Staff Services at the community hospital who confirmed that no additional formal review was
required at the institution prior to implementation.
Results
Prior to the educational offering, baseline knowledge and utilization of low-dose ketamine
was established. Approximately, 78% of respondents had heard about and correctly identified the
correct low-dose ketamine range (see Figure 1), but only 44% stated they were aware that lowdose ketamine limited CNS side effects (see Figure 2). Some 78% of respondents also stated they
had utilized low-dose ketamine in any surgical population, but only 44% had utilized it in
thoracotomy.

Figure 1: Baseline Low-Dose Ketamine Dose
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Figure 2: Baseline CNS Side Effects
After the in-service, identification of the correct range for low-dose ketamine increased to
100% and limited CNS side-effects to 89%, both clinically significant improvements.
Additionally, all CRNAs responded affirmatively when asked if they were willing to consider a
practice change, utilizing low-dose ketamine in thoracotomies, with 89% indicating they were
either moderately or extremely likely to consider this change. No concerns over this practice
change or the material presented were raised by the CRNAs present.
After 60 days, the follow-up questionnaires were distributed. Only three of the nine CRNAs
who responded had the opportunity to provide anesthesia during a thoracotomy since the
educational offering. Of those, two utilized low-dose ketamine. The remaining CRNA who did
not expressed concern related to the patient’s advanced age. Both CRNA’s who utilized lowdose ketamine reported that in their clinical judgement, both pain and opioid consumption were
reduced. The remaining six CRNAs who did not have the opportunity to utilize low-dose
ketamine showed a slight decrease in their willingness to change their practice in this patient
population. No concerns were raised with the guidelines for utilization that were provided. One
CRNA requested an accompanying protocol for in-patient ketamine utilization so that the option
to continue the infusion in the postoperative period was available.

22
Discussion
Summary
Low-dose IV ketamine, when administered intraoperatively during thoracotomy
procedures, can reduce postoperative pain and opioid consumption. Increasing anesthesia
provider awareness of this technique through education encouraged a practice change, allowing
patients to realize these benefits and ease the burden of recovery from this difficult procedure.
This project exemplified a DNP project by aligning with the DNP Essentials I, II, III, VI, and
VIII (American Association of Colleges of Nursing, 2006). Essential I, Scientific Underpinnings
for Practice, was embodied by using a theoretical framework to guide this DNP project. Essential
II, Organizational and Systems Leadership for Quality Improvement and Systems Thinking, was
fulfilled as this quality improvement project utilized scientific findings to guide patient care.
Essential III, Clinical Scholarship and Analytical Methods for Evidence-Based Practice, was the
essence of this DNP project as existing evidence was appraised and synthesized into practice.
Essential VI, Interprofessional Collaboration for Improving Patient and Population Health
Outcomes, was addressed as the primary audience for this project was both CRNAs and
anesthesiologists. Finally, Essential VIII, Advanced Nursing Practice, was represented by using
advanced clinical judgement in the design, delivery, and evaluation of this evidence-based
project.
Interpretation
The educational offering as a live in-service was effective in both teaching and
persuasion. This was demonstrated by the clinically significant increase in both knowledge of
low-dose ketamine and willingness for a practice change. This offers support that brief live
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presentations can be valid teaching tools, which frequently occur during staff meetings and
journal clubs.
Unfortunately, only nine CRNAs responded to the surveys. As a community hospital, a
smaller number of anesthesia providers are employed there than larger university centers. Low
numbers were anticipated for this site, but this small sample size did contribute to very little
changes in data required to meet clinical significance. For instance, clinical significance of
correctly identifying the correct range for low-dose ketamine was obtained, but the increase was
only from seven to nine CRNAs.
The clinical judgement of the CRNAs who utilized low-dose ketamine that pain and
opioid consumption was reduced correlates with the data discovered during literature review.
The CRNA who chose not to use low-dose ketamine based on the patient’s age was justified in
his or her thinking. In most RCTs reviewed for this project, age less than 65 years old was a
common exclusion criterion. Additionally, pre-procedure midazolam was suggested to further
reduce CNS side effects of ketamine; however, midazolam given to patients over 65 can increase
the likelihood of postoperative delirium.
Overall, all CRNAs expressed a willingness to adopt a practice change regarding lowdose ketamine utilization. However, a slight decrease in the degree of willingness was noted
from the end-of-session to follow up survey. At the completion of the educational offering, 5 of 9
CRNAs chose “extremely likely” when asked if they would be willing for a practice change (see
Figure 3). At the completion of the project, that total had been reduced to 3 of 9 (Figure 4). The
lack of opportunity to quickly utilize this intervention shortly after information delivery may
have been responsible for this. As time goes by, excitement and eagerness to implement new
ideas and evidence into practice wanes if an opportunity to do so is not provided.
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Figure 3: End-of-Session Willingness for Practice Change

Figure 4: 60-Day Follow-Up Willingness for Practice Change
Finally, it should also be noted that there were several “inappropriate” responses to the
final follow-up survey. Several respondents noted that ketamine was useful in reducing pain and
opioid consumption despite not actually having the opportunity to implement the intervention.
One reason for this faulty response could have been formatting issue with the survey that may
have confused the CRNA. Another potential reason may be that the respondents were eager to
please the surveyor, a common phenomenon among those completing surveys. At the time of the
final survey, the co-lead investigator was enrolled in a clinical rotation at the hospital and had
discussed the project with several of the staff CRNAs. The CRNAs may have felt that
responding affirmatively to the survey would enhance the investigator’s standing in the Nurse
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Anesthetist Program or would generally please the investigator to know his intervention was
successful.
Limitations
Both time and the relatively low volume of thoracotomy procedures performed at the
community hospital proved to be limiting factors in providing most anesthesia providers with an
opportunity to utilize this proposed practice change. The small sample size made clinical
significance easy to obtain but limits the generalizability of the results. This small sample size
was anticipated. Despite the small sample, the co-lead investigator, based on previous
experience, felt compelled to introduce this evidence in this facility, as he felt strongly that the
patients in this facility deserved the same high quality of care as those in larger teaching
institutions.
Additional factors may have limited the internal validity of the results. As previously
stated, several respondents rated the effectiveness of ketamine despite answering that they had
not performed the intervention. This may have been related to poor survey formatting or a bias of
the respondents to please the surveyor. The investigator also could have been more precise in
distributing and tracking survey results. An improved design would have randomly assigned
each CRNA an identification number. This number would have allowed surveys to remain
anonymous, but the investigators could have then tracked individual improvement in knowledge
and willingness to implement this practice change, rather than just the group as a whole.
Finally, the scope of this project as an academic DNP project limits the measurement of
ketamine’s effectiveness. The general focus of this project was based on a system change
(increased knowledge and willingness to implement a practice change) rather than health
outcomes. Based on this direction, it was determined that measuring ketamine’s effectiveness
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was best accomplished by surveying the CRNA’s clinical judgement. A quantitative RCT similar
to those found in the literature review measuring patient reported pain scores and documented
opioid consumption would provide more definitive data on low-dose ketamine’s effectiveness in
thoracotomies at this facility.
Conclusions
This project met each objective delineated prior to implementation. The educational
offering increased provider awareness of both the appropriate dose of low-dose ketamine as well
as reduced CNS side effects associated with this lower dose. After the offering, both immediately
and after time had passed, anesthesia providers reported a willingness to implement this practice
change. Finally, regarding the ultimate goal to improve anesthesia care at this site, pain and
opioid consumption was reduced in the eyes of the nurse anesthetists afforded the opportunity to
implement low-dose ketamine in thoracotomies.
Given the success of this project, this intervention should be sustained at this site. This
quality improvement project met the mission of the hospital in providing patient-centered care,
as well as the values of innovation and excellence. The anesthetists who were able to implement
this intervention are in position to be the best facilitators of the effectiveness of low-dose
ketamine, as they can recount first-hand knowledge of its utility to their fellow nurse anesthetists.
Few barriers exist to continuing this intervention. First, as with many things post-COVID, a
continuous available supply of ketamine is far from guaranteed. Additionally, as previously
stated, more effective techniques or medications could be discovered. Finally, anesthesia
providers must understand the goal is to reduce opioid consumption, not eliminate it. Low-dose
ketamine is intended to be an adjunct in multi-modal analgesia in thoracotomies. For example, a
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patient can be offered both a thoracic epidural and ketamine as a multi-modal approach to their
postoperative pain management.
Several recommendations are appropriate for this site following the success of this
intervention. Low thoracotomy volumes may make it difficult to sustain in this population alone,
but as the literature reveals, this intervention can be useful to other patient populations where
severe postoperative pain may be anticipated, such as open abdominal or populations.
Additionally, the genesis of this project was in the co-chief CRNA’s desire to implement ERAS
in this facility. Therefore, another avenue for expansion would be to implement additional ERAS
elements in thoracotomies or other patient populations. Finally, as requested by a staff CRNA, a
protocol allowing for in-patient use of ketamine infusions would likely increase intraoperative
utilization.
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Appendix A: Evaluation Table
Year

Citation:
Author, Title,
Country
2019 Pehlivan, S.,
The Effect of
Low Dose
Ketamine
Infusion on
Postoperative
Acute and
Chronic Pain
After
Thoracotomy.
Turkey

Purpose of the
Study

Sample
Description

Hypothesis:
low dose
ketamine will
reduce acute and
chronic pain
after thoracic
surgery

N = 40
Pop:
thoracotomy
No significant
difference in
demographics
EC:
uncontrolled
hypertension,
diabetes
mellitus, drug
use due to
chronic pain,
psych hx, opioid
addiction,
severe liver
and/or renal
failure
- Estimated need
for significance:
20/group

Design /
Independent
Variables
Double-blind
RCT
IdV1: Ketamine
(K)
IdV2: Control
Each group of
20 had their
assigned med
started preincision and
continued for
the first 24
hours postop
-No Attrition

Measures /
Dependent
Variables
DV1: Pain
rating at rest and
moving using
VAS at 2, 6, 12,
and 24 hr postop
DV2: total
morphine
consumption
DV3:
pulmonary
function
DV4: chronic
pain at 1- and 3months postop

Findings
(statistically
significant)
Group K has:
- lower pain
scores at rest
and movement
at all time
markers
- Less morphine
consumption
- Less chronic
pain at 3 months
(but not 1
month)
*no difference
in pulmonary
performance

Appraisal/Comments
- The effect of decreased
acute and chronic pain
appears to be r/t to lowdose IV ketamine use in
this study.
- The authors do state
that measuring chronic
long-term effects would
be more effective in a
larger sample size.
- Ketamine continued for
first 24-hours postop
- Group K does not add
up to 20. If a surgery
type was not performed,
they used an (-) to mark
this. My assumption is
that the 0 for lung
resection and
pneumonectomy under
group K is a typo and
should be 7. This plus
does decrease the clarity
of the article and brings
up a certain level of
doubt regarding the peer
review.

2015 Choi E.
Effect of
intraoperative
infusion of
ketamine on
remifentanilinduced
hyperalgesia.
India

To show highdose
remifentanil can
induce OIH, and
to confirm that
OIH and opioid
consumption
can be
diminished with
intraoperative
IV ketamine use

N = 75
Pop =
Laparoscopic
gynecological
surgery
No significant
difference in
demographics
EC: PMH
opioid use,
alcohol abuse,
psych dx
- Estimated need
for significance:
24/group

RCT
IdV1: RL
IdV2: RH
IdV3: KRH
3 groups of (25)
patients. In the
OR, the first
group was given
low-dose
remifentanil, the
second group
high-dose
remifentanil,
and the third
group high-dose
remifentanil +
ketamine
starting at
induction and
ending at final
suture.
- No attrition

DV1: Time to
first postop
analgesic and
total analgesic
consumption
DV2: Pain
rating post up
using NRS at 0,
1, 6, and 24 hr
postop
DV3: Tactile
sensitivity
postop via
Touch-Test to
evaluate
hyperalgesia

RH Group:
- Greater PACU
analgesic use
than RL
- Greater
cumulative
fentanyl dose 48
hr postop than
other 2 groups
- higher NRS at
6- and 24-hour
postop than
other 2 groups
- Lower touch
test value,
greater pre/post
op difference in
touch-test for at
48-hour postop
than other 2
groups
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- Demonstrates OIH and
Ketamine can reduce this
phenomenon.
- Intra-op only.
- RL required higher
concentrations of
desflurane intra-op but
does not discuss any
possible ramifications.
- Study does not state
that was double-blind
- Study does not give all
p-values, only notes
when RH p < 0.05
compared to other
groups. Reader can’t
determine if significance
exists between RL and
KRH, or if there are
values that may be
clinically significant.
- The authors never
mention a direct
comparison between the
RL and KRH groups.
There is appears to be
little difference in postop
pain, opioid
consumption, and
hyperalgesia. If this is
true, then why not
simply use RL and avoid
OIH in the first place?
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2015 Kaur, S.
Effect of
intraoperative
infusion of lowdose ketamine
on management
of postoperative
analgesia.
India

Hypothesis:
intraoperative
low-dose
ketamine may
have opioid
sparing effect

N = 80
Pop: Open
Choley
No significant
difference in
demographics
EC: Chronic
analgesic use,
PMH cardiac,
hepatic, renal,
pulmonary,
neuro, psych,
endocrine,
myopathy, or
pregnant
women.
- Estimated need
for significance:
30/group

Double-blind
RCT
IdV1: Ketamine
(K)
IdV2: Control
Each group of
(40) received
pre-incision
bolus and intraop infusion of
assigned med.
Infusion stopped
at skin closure.
- No attrition

DV1: Pain
rating post up
using VAS at 2,
4, 6, 12, and 24
hr postop
DV2: total
morphine used
in 24hr postop
DV3: use of
rescue analgesia
(morphine)
DV4: patient
satisfaction at
24 hr postop

Group K has:
- Lower pain
scores 0-6 hr
postop, but
difference was
not significant
for 12 and 24hr.
- Reduction in
morphine use
- Reduction in
rescue morphine
requirement
- No difference
in patient
satisfaction
scores

- Decreased pain and
opioid use is related to
intraoperative IV
ketamine use.
- The ketamine appears
to “wear off” after the 6hour mark in this
population. The
decreased pain in this 6hour window likely
accounts for the
decreased opioid
consumption.
- Only 5/40 ketamine
patients required a rescue
analgesic dose of IV
morphine, compared to
40/40 of the control
group.
- Low-dose ketamine
was used, proved
effective in reduced
opioid consumption, and
no patients showed
severe postoperative side
effects (table 4).
- The author’s state that
intra-op opioid infusion
was not used to avoid
masking the analgesic
measurement of
ketamine.
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2011 Subramaniam,
K.
Intra- and
Postoperative
Very Low Dose
Intravenous
Ketamine
Infusion Does
Not Increase
Pain Relief after
Major Spine
Surgery in
Patients with
Preoperative
Narcotic
Analgesic
Intake.
U.S.

To demonstrate
the analgesic
efficacy and
opioid-sparing
effect of low
dose ketamine
in patients with
preop narcotic
intake

*N = 38
Pop: Lumbar
laminectomy
and fusion for
back pain with
preop narcotic
analgesic intake
No significant
difference in
demographics
EC: PMH
severe cardiopulmonary
disease, severe
uncontrolled
hypertension,
raised
intracranial
pressure,
glaucoma,
hepato-renal
dysfunction,
pregnancy, and
psychosis.
*Estimated need
for significance:
26/group

Double-blind
RCT
IdV1: Ketamine
(K)
- Attrition: 5
mid-study
-15 total
evaluated
IdV2: Control
- Attrition: 3
mid-study
-15 total
evaluated
Each group had
their assigned
med started at
induction and
continued for
the first 24
hours postop

DV1: Pain
rating post up
using VAS at 0,
1, 2, 4, 8, 12,
18, 24, 36, and
48 hr postop
DV2: narcotic
requirement first
48 hr postop
DV3: side
effects

There was no
significant
difference in
postop pain,
narcotic
requirement, or
side effects in
the two groups
*Interim
analysis was
performed, and
the study halted
as the study was
showing no
change in
analgesia and
concern for
increased CNS
effects

- 8/38 (21%) Attrition:
Only 2 for CNS side
effects, 1 from each
group. The others were
for reasons not r/t IdV.
- Preop opioid use is
often an EC for other
studies.
- The author’s note that
preop opioid use is a
minimum of two weeks.
The type, dose, and
duration of this use were
not controlled or factored
into their analysis, this
could have influenced
the results of the trial.
- Clinical judgement was
used to halt the study,
interim stats validate.
- Based on this study
alone, IV ketamine
would not be an
appropriate medication
in patients with preop
opioid use.
- A trial with these same
parameters in a nonorthopedic population
may be considered. If the
results are similar, then
opioid use for chronic
pain may dissuade
ketamine use across all
surgical populations.
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2004 Ozyalcin, N.S.
Effect of preemptive
ketamine on
sensory changes
and
postoperative
pain after
thoracotomy:
comparison of
epidural and
intramuscular
routes.
Country not
stated in study

To evaluate the
efficacy of preemptive
ketamine via IM
and epidural
routes to control
acute and
chronic postop
pain

DV: Dependent Variable
EC: Exclusion Criteria
EPI: Epidural
IdV: Independent Variable
IM: Intramuscular
IV: Intravenous
KRH: high-dose remifentanil + Ketamine
N: Sample Number
NRS: Numeric Rating Scale for pain

N = 60
Pop:
Thoracotomy
No significant
difference in
demographics
EC: drug and
alcohol abuse,
ischemic heart
disease, psych
hx, chronic low
back pain.
- Estimated need
for significance:
Not stated

Double-blind
RCT
IdV1: IM
IdV2: EPI
IdV3: Control
Each group of
(20) patients
were
administered
their assigned
med via bolus
only 15 minutes
before
anesthesia
induction.
- No attrition

DV1: Pain
rating post up
using VAS at 2,
4, 6, 8, 10, 12,
24, and 48 hr
postop
DV2: analgesia
consumption in
same time frame
as above
DV3: pin-prick
hyperalgesia 2,
15, and 30 days
postop

Group EPI has:
-Less intra-op
fentanyl use
than control
-Less postop use
of analgesia
than both other
groups
-Reduced pinprick
hyperalgesia vs
both groups at
day 2 and 15
postop

NS: Normal Saline
OIH: Opioid-Induced Hyperalgesia
PMH: Past Medical History
Pop: Patient Population
RCT: Randomized Control Trial
RH: High-Dose Remifentanil
RL: Low-Dose Remifentanil
VAS: Visual Analog Scale

- This study is older, and
I have not noted much
discussion of IM
ketamine use in recent
articles.
- That said, this is a very
good comparison of
ketamine vs no ketamine
in a double-blind study
showing significant
reduction in opioid
consumption.
- Dose is bolus only, no
continuous infusion.
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Appendix B: Synthesis Table
A
Population: Thoracotomy
Interventions
1. Postoperative pain
2. Postoperative opioid consumption.
Additional Considerations
1. RCT
2. Ketamine use beyond OR

Studies
C

E
X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X
X

X

X

X
X

5. Postoperative CNS side effects reported
6. Postoperative PCA for pain control

D

X

3. Hyperalgesia measured
4. Chronic opioid use as exclusion criterion

B

X
X

X

X

Legend: A = Pehlivan, 2019; B = Choi, 2015; C = Kaur, 2015; D = Subramaniam, 2011; E = Ozyalcin, 2004.
X indicates presence of the intervention/consideration.

X

X
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Appendix C: SMART Work Plan
Project Goals: Complete and submit project proposal to IRB

*SMART Objective

Activities

Projected
Completion Date

Develop a faculty
approved DNP project

1. Identify a problem
2. Perform systematic review
related to the problem

Completed Spring
2020

Dr. Frame

Develop first draft of
project proposal

1. Research and synthesize
background
2. Update literature
3. Perform Needs Assessment
& SWOT Analysis
4. Identify Theoretical
Framework
5. Develop project goals and
plan
6. Develop evaluation plan
7. Assemble and compose
first draft
1. Meet with stakeholders at
hospital
2. Obtain verbal approval
3. Obtain written approval
1. Search literature
2. Synthesize literature
3. Develop recommendations
for low-dose ketamine use

Completed
Summer 2020

Dr. Frame
Dr. Barker
Peer Review

Evaluation Plan (Describe
measures used to assess
satisfaction, project
outcomes, benefits of
activities, etc.)
Approval to proceed to
proposal phase of project
received.
Draft completed and
submitted on time for
review.

Completed
Summer 2020

Co-chief CRNA

Written approval received.

1.
2.
3.
4.
5.

DNP Team

Educational presentation
developed.

Identify location for
project implementation.
Develop an educational
presentation about lowdose ketamine utilization
in thoracotomy.

Complete
Complete
August 31, 2020
August 31, 2020
September 2020

Projected
Number
of People
Reached

Organization(s)/
Partner(s)
collaborating with
to conduct activity

39
4. Develop pre- and postsurveys
5. Synthesize presentation

Finalize and present
project proposal to IRB
for approval

1. Revise first draft of project
proposal.
2. Submit for review by Dr.
Frame
3. Revise and submit for
review by Dr. Frame
4. Submit to IRB

1.
2.
3.
4.

Dr. Frame

September 2020
September 2020
October 2020
November 2020

Proposal submitted to IRB
for approval by November
2020

Project Goals: Implement and evaluate DNP project at large community hospital

*SMART Objective

Activities

Projected
Completion Date

Complete development
of the educational
presentation about lowdose ketamine utilization
in thoracotomy

1. Update literature review
2. Ascertain appropriate
delivery method of
presentation
3. Review and update
presentation
4. Submit for final review by
Dr. Frame
1. Establish appropriate time
for presentation
2. Conduct pre-test/survey
3. Present evidence to
anesthesia department
4. Posttest/survey

December 31,
2020

Implement the
educational presentation
to the anesthesia dept at
community hospital by
January 2021

January 2021

Projected
Number
of People
Reached

Organization(s)/
Partner(s)
collaborating with
to conduct activity
DNP Team

27

Anesthesia Dept.

Evaluation Plan (Describe
measures used to assess
satisfaction, project
outcomes, benefits of
activities, etc.)
Presentation and associated
combination test and surveys
completed.

Pre-test/survey
Immediate post-test/survey
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Evaluate anesthesia
department feedback
regarding low-dose
ketamine utilization 60
days after in-service

1. Analyze results of initial
surveys.
2. Conduct final survey
3. Analyze and evaluate
results of DNP Project.

Spring 2021

27

Anesthesia Dept.
DNP Team

Data evaluated.

Projected
Number
of People
Reached

Organization(s)/
Partner(s)
collaborating with
to conduct activity

Evaluation Plan (Describe
measures used to assess
satisfaction, project
outcomes, benefits of
activities, etc.)
Manuscript reviewed and
approved by FOR

Project Goals: Present Findings of DNP Project

*SMART Objective

Activities

Projected
Completion Date

Synthesize written
manuscript of DNP
project
Present DNP Project

1. Write, write, write
2. Review

Summer/Fall 2021

Dr Frame

1. Develop presentation
2. Present

Spring 2022

Dr Frame

Presented

*SMART is a simple acronym used to set objectives. It stands for: 1. Specific – Objectives should specify what they want to achieve;
2. Measurable – You should be able to measure if you are meeting the objectives or not; 3. Achievable - Are the objectives you set,
achievable and attainable; 4. Realistic – Can you realistically achieve the objectives with the resources you have; and 5. Time – When
do you want to achieve the set objectives.
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Appendix D: Educational In-service Outline
•

Background and significance of pain and opioid consumption after thoracotomy.

•

Literature summary establishing the benefits of low-dose ketamine.

•

Define “low-dose” range for ketamine.

•

Define inclusion criteria

•

Define contraindications

•

Define precautions

•

Provide recommendations for intraoperative ketamine utilization.
o

Preop medications

o

Induction dosing

o

Maintenance dosing

o

Special considerations
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Appendix E: Recommendations for Utilization
•

Inclusion criteria
o

Population: Patients undergoing thoracotomy

o

ASA I-III

•

Contraindications: Hypersensitivity to ketamine and severe hypertension

•

Precautions: Hypertension, cardiomyopathy, arrhythmia, elevated intracranial pressure,
glaucoma, hepatic or renal failure, obstetrics, non-schizophrenia related hallucinations or
psychosis, chronic alcoholism, and schizophrenia

•

Recommendations for ketamine utilization.
o

Preop: Versed is suggested as to further limit the risk for emergence delirium

o

Induction

o

o

§

Ketamine Bolus: 0.5 mg/kg over 60 seconds

§

Additional induction medications per provider preference

Maintenance dosing of ketamine: 0.1-0.3 mg/kg/hr.
§

May be continuous infusion or repeated bolus per provider preference.

§

If continuous infusion used, stop at closure.

Special considerations.
§

Geriatric use: consider using half-recommended dose for age > 65

§

VATS: Consider utilizing repeated bolus method as VATS may progress to
thoracotomy

§

Avoid concurrent use of Precedex as this may prolong emergence.
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Appendix F: Letter of Support
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Appendix G: Surveys
Pre-survey
•

•

Goals
o

Establishing baseline knowledge

o

Evaluating utilization prior to in-service

Possible Sample Questions
o

Have you ever read about or listened to a discussion about the usefulness of low-dose
ketamine?

o

What dose do you consider “low-dose” regarding ketamine?

o

Are you aware that the evidence reports limited CNS side effects with the utilization of
low-dose ketamine?

o

Have you ever included low-dose ketamine in your anesthesia practice?
§

If yes, for what surgical population?

§

In your clinical judgement, how effective was low-dose ketamine in:
•

Reducing post-operative pain?

•

Reducing post-operative opioid consumption?

End-of-session questionnaire
•

•

Goals:
o

Evaluate teaching

o

Determine willingness for practice change

o

Allow those resistant an opportunity to express concerns.

Questions
o

What dose is considered “low-dose” for ketamine?

o

Are CNS side effects a significant concern with low-dose ketamine?

o

What is the benefit(s) of utilizing low-dose ketamine in the delivery of anesthesia?
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o

How likely are you to consider a change in practice by including low-dose ketamine
usage for the care of thoracotomy patients? (Likert scale to be provided)
§

If not at all, please explain why you are unwilling to consider this practice
change.

o

Do you have any feedback or suggestions to offer concerning the in-service delivery or
content presented?

60-day Follow-up
•

•

Goals
o

Determine if practice change has been made

o

Gather feedback on effectiveness

o

Gather feedback on guidelines

o

Allow those resistant an opportunity to express concerns.

Questions
o

Have you provided anesthesia to a thoracotomy patient since participating in the lowdose ketamine in-service?
§

If no, how likely are you to consider a change in practice by including low-dose
ketamine usage for the care of thoracotomy patients?

§

If yes, did you use low-dose ketamine in the anesthesia care of this patient(s)?
•

If no, please explain why you chose not to administer low-dose ketamine
to this patient(s).

•

If yes, in your clinical judgement, how effective was low-dose ketamine
in:
o

Reducing post-operative pain? (Likert scale to be provided)

o

Reducing post-operative opioid consumption? (Likert scale to be
provided)
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o

How likely are you to consider using low-dose ketamine in the anesthesia care of other
major surgeries with similar post-operative pain and opioid consumption? (Likert scale to
be provided)

o

Do you have any feedback or suggestions to offer concerning the guidelines for
utilization?

